Both in Diagnostics
BIOMERICA vs Myriad Genetics
Over the past year BMRA returned −40.3% and MYGN returned −18.5%; their daily moves had a correlation of 0.11.
BMRA −40.3% MYGN −18.5%Growth of $1, one year, split-adjusted
| Metric | BMRA | MYGN |
|---|---|---|
| Price | $1.75 | $6.63 |
| Market cap | $8.0M | $634.2M |
| Today | +2.34% | +5.41% |
| 1 month | −23.9% | +56.7% |
| 6 months | −19.0% | +41.7% |
| Year to date | −30.6% | +7.8% |
| 1 year | −40.9% | −18.1% |
| Revenue growth (YoY) | −8.3% | −10.5% |
| Gross margin | 8.1% | 66.6% |
| Net margin | −97.4% | −22.7% |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | 0.8× |
| Net cash | $2.7M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 72.9% | 82.0% |
| Short % of float | 0.3% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).